Literature DB >> 6874890

The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.

M Kwan, W J Greenleaf, J Mann, L Crapo, J M Davidson.   

Abstract

Sexual function and the effects thereon of testosterone enanthate were studied in six hypogonadal men with the objective of delineating the specific components of male sexuality affected by androgen. To obtain a detailed picture of these components, prospective self-report data (from daily logs) of sexual activity and feelings, recordings of all night penile tumescence, and laboratory psychophysiological data were assessed. Double blind placebo experiments with cross-over design were used to compare the effects of placebo and 200- and 400-mg doses of testosterone enanthate. Erectile responses to erotic film and fantasy were not lower in the hypogonadal patients than in normal men and, in fact, were higher on some parameters, especially prolongation of detumescence time after exposure to film or fantasy. Three subjects who kept consistent daily logs had increased frequencies of sexual acts and feelings, orgasms, and spontaneous erections after testosterone administration. Nocturnal penile tumescence and spontaneous daytime erections were reduced in untreated hypogonadal men and were significantly increased after testosterone treatment, but the laboratory-tested erectile responses to film and fantasy were not affected by testosterone. These data and previous findings lead to the conclusion that the major androgen action on male sexuality involves libido factors (i.e. sexual motivation/interest). Though stimulus-bound erections elicited in the laboratory were not reduced in hypogonadal men, spontaneous (sleep or waking) erections were clearly testosterone dependent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874890     DOI: 10.1210/jcem-57-3-557

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

Review 1.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Isolated hypogonadotropic hypogonadism in male identical twins.

Authors:  F Geola; J M Hershman
Journal:  West J Med       Date:  1989-01

4.  Gonadal steroids and body composition, strength, and sexual function in men.

Authors:  Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

Review 5.  Medical treatment of erectile dysfunction.

Authors:  N Burns-Cox; C Gingell
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

6.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

7.  Penile tumescence monitoring during morning naps to assess male erectile functioning: an initial study of healthy men of varied ages.

Authors:  C M Gordon; M P Carey
Journal:  Arch Sex Behav       Date:  1995-06

8.  Evaluation of impotence in older men.

Authors:  S S Davis; S P Viosca; M Guralnik; C Windsor; M W Buttiglieri; J D Baker; A J Mehta; S G Korenman
Journal:  West J Med       Date:  1985-04

Review 9.  Erectile dysfunction: management update.

Authors:  Luke Fazio; Gerald Brock
Journal:  CMAJ       Date:  2004-04-27       Impact factor: 8.262

10.  The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism.

Authors:  O Mohamed; R E Freundlich; H K Dakik; E D Grober; B Najari; L I Lipshultz; M Khera
Journal:  Int J Impot Res       Date:  2009-08-06       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.